149 related articles for article (PubMed ID: 38770671)
21. Synchronous and metachronous cancers in patients with gastric cancer.
Eom BW; Lee HJ; Yoo MW; Cho JJ; Kim WH; Yang HK; Lee KU
J Surg Oncol; 2008 Aug; 98(2):106-10. PubMed ID: 18452218
[TBL] [Abstract][Full Text] [Related]
22. Second primary lung cancer.
Antakli T; Schaefer RF; Rutherford JE; Read RC
Ann Thorac Surg; 1995 Apr; 59(4):863-6; discussion 867. PubMed ID: 7695410
[TBL] [Abstract][Full Text] [Related]
23. Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.
Kumar R; Price TJ; Beeke C; Jain K; Patel G; Padbury R; Young GP; Roder D; Townsend A; Bishnoi S; Karapetis CS
Clin Colorectal Cancer; 2014 Jun; 13(2):87-93. PubMed ID: 24373733
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of a prognostic scoring system for patients with colorectal cancer hepato-pulmonary metastasis: a retrospective study.
Deng S; Jiang Z; Cao Y; Gu J; Mao F; Xue Y; Qin L; Liu K; Wang J; Wu K; Cai K
BMC Cancer; 2022 Jun; 22(1):643. PubMed ID: 35690752
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological features, risk and survival in lung cancer survivors with therapy-related acute myeloid leukaemia.
Wang H; Yin Y; Wang R; Huang J; Xue H; Cheng Y; Zhang L; Chen C
BMC Cancer; 2020 Nov; 20(1):1081. PubMed ID: 33172389
[TBL] [Abstract][Full Text] [Related]
26. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
Hentzen JEKR; Rovers KP; Kuipers H; van der Plas WY; Been LB; Hoogwater FJH; van Ginkel RJ; Hemmer PHJ; van Dam GM; de Hingh IHJT; Kruijff S
Ann Surg Oncol; 2019 Jul; 26(7):2210-2221. PubMed ID: 30877495
[TBL] [Abstract][Full Text] [Related]
27. Synchronous and metachronous colorectal cancers: distinct disease entities or different disease courses?
Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
Hepatogastroenterology; 2015; 62(138):286-90. PubMed ID: 25916050
[TBL] [Abstract][Full Text] [Related]
28. The Value of Prognostic Factors for Survival in Synchronous Multifocal Lung Cancer: A Retrospective Analysis of 164 Patients.
Lv J; Zhu D; Wang X; Shen Q; Rao Q; Zhou X
Ann Thorac Surg; 2018 Mar; 105(3):930-936. PubMed ID: 29394993
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Factors Analysis and Nomogram Construction of Dual Primary Lung Cancer: A Population Study.
Song CK; Guo ZX; Shen XY; Wang YJ; Wang QW; Yu DH; Chen C; Liu XP; Huang JY; Li S; Hu W
Biomed Res Int; 2020; 2020():7206591. PubMed ID: 32149127
[TBL] [Abstract][Full Text] [Related]
30. Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma.
Liang Z; Zhang E; Duan L; Weygant N; An G; Hu B; Yao J
Technol Cancer Res Treat; 2022; 21():15330338211068960. PubMed ID: 35179409
[No Abstract] [Full Text] [Related]
31. Clinicopathologic features and prognosis of synchronous and metachronous multiple primary colorectal cancer.
Zhang C; Cui M; Xing J; Yang H; Yao Z; Zhang N; Su X
Clin Transl Oncol; 2021 Feb; 23(2):335-343. PubMed ID: 32592156
[TBL] [Abstract][Full Text] [Related]
32. Predictive potential of preoperative Naples prognostic score-based nomogram model for the prognosis in surgical resected thoracic esophageal squamous cell carcinoma patients: A retrospective cohort study.
Guo XW; Ji L; Xi XX; Zhao WW; Liu YC; Zhou SB; Ji SJ
Medicine (Baltimore); 2024 May; 103(18):e38038. PubMed ID: 38701277
[TBL] [Abstract][Full Text] [Related]
33. Surgical treatments for multiple primary adenocarcinoma of the lung.
Nakata M; Sawada S; Yamashita M; Saeki H; Kurita A; Takashima S; Tanemoto K
Ann Thorac Surg; 2004 Oct; 78(4):1194-9. PubMed ID: 15464469
[TBL] [Abstract][Full Text] [Related]
34. Prognostic nomogram predicts overall survival in pulmonary large cell neuroendocrine carcinoma.
He Y; Liu H; Wang S; Chen Y
PLoS One; 2019; 14(9):e0223275. PubMed ID: 31560723
[TBL] [Abstract][Full Text] [Related]
35. A novel nomogram with preferable capability in predicting the overall survival of patients after radical esophageal cancer resection based on accessible clinical indicators: A comparison with AJCC staging.
Li X; Xu J; Zhu L; Yang S; Yu L; Lv W; Hu J
Cancer Med; 2021 Jul; 10(13):4228-4239. PubMed ID: 34128338
[TBL] [Abstract][Full Text] [Related]
36. Postoperative Management of Multiple Primary Cancers Associated with Non-small Cell Lung Cancer.
Shoji F; Yamazaki K; Miura N; Katsura M; Oku Y; Takeo S; Maehara Y
Anticancer Res; 2018 Jun; 38(6):3773-3778. PubMed ID: 29848742
[TBL] [Abstract][Full Text] [Related]
37. Nomogram prediction of overall survival for patients with non-small-cell lung cancer incorporating pretreatment peripheral blood markers.
Xie D; Allen MS; Marks R; Jiang G; Sun Z; Nichols F; Zhang M; Chen C; Aubry MC; Jatoi A; Garces YI; Mansfield A; Wigle D; Molina J; Deschamps C; Yang P
Eur J Cardiothorac Surg; 2018 Jun; 53(6):1214-1222. PubMed ID: 29293957
[TBL] [Abstract][Full Text] [Related]
38. Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung.
Li H; Wang Z; Yang F; Wang J
J Surg Oncol; 2020 May; 121(6):1027-1035. PubMed ID: 32026478
[TBL] [Abstract][Full Text] [Related]
39. Survival nomograms for vulvar squamous cell carcinoma based on the SEER database and a Chinese external validation cohort.
Zhao Z; Zhen S; Liu N; Ding D; Zhang D; Kong J
Int J Gynaecol Obstet; 2024 Jun; 165(3):1130-1143. PubMed ID: 38240461
[TBL] [Abstract][Full Text] [Related]
40. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
Chai Y; Ma Y; Feng W; Lu H; Jin L
World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
